• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.

作者信息

Al Nokhatha Shamma, MacEoin Neil, Conway Richard

机构信息

RCPI, Dublin, Ireland.

Tawam Hospital, Al Ain, UAE.

出版信息

Ann Rheum Dis. 2021 Oct;80(10):e170. doi: 10.1136/annrheumdis-2021-219847. Epub 2021 Jan 28.

DOI:10.1136/annrheumdis-2021-219847
PMID:33509797
Abstract
摘要

相似文献

1
Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.关于“COVID-19大流行对炎症性风湿和肌肉骨骼疾病患者管理决策的影响：欧洲抗风湿病联盟国家的一项调查”的通信
Ann Rheum Dis. 2021 Oct;80(10):e170. doi: 10.1136/annrheumdis-2021-219847. Epub 2021 Jan 28.
2
Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha .对Nokhatha所著《关于“COVID-19大流行对炎症性风湿和肌肉骨骼疾病患者管理决策的影响：欧洲抗风湿病联盟国家的一项调查”的通信》的回复
Ann Rheum Dis. 2021 Oct;80(10):e171. doi: 10.1136/annrheumdis-2021-219866. Epub 2021 Jan 28.
3
Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1).探索风湿性和肌肉骨骼疾病患者组织在新冠疫情期间的作用：REUMAVID研究（第一阶段）的结果
Clin Exp Rheumatol. 2022 May;40(5):1062-1063. doi: 10.55563/clinexprheumatol/g4irgy. Epub 2022 Jan 27.
4
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.EULAR 临时推荐意见：在 SARS-CoV-2 背景下管理风湿和肌肉骨骼疾病。
Ann Rheum Dis. 2020 Jul;79(7):851-858. doi: 10.1136/annrheumdis-2020-217877. Epub 2020 Jun 5.
5
Correspondence on "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry" by Machado .关于马查多所著的《风湿性和肌肉骨骼疾病患者接种新型冠状病毒疫苗的安全性：欧洲抗风湿病联盟冠状病毒疫苗（COVAX）医生报告登记处的结果》的通信
Ann Rheum Dis. 2023 Dec;82(12):e228. doi: 10.1136/annrheumdis-2022-222118. Epub 2022 Jul 11.
6
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.COVID-19 大流行对炎症性风湿和肌肉骨骼疾病患者管理决策的影响：一项在 EULAR 国家开展的调查。
Ann Rheum Dis. 2021 Apr;80(4):518-526. doi: 10.1136/annrheumdis-2020-218697. Epub 2020 Nov 6.
7
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.欧洲抗风湿病联盟关于2019冠状病毒病背景下风湿性和肌肉骨骼疾病患者管理及疫苗接种的建议：2021年11月更新版
Ann Rheum Dis. 2022 Dec;81(12):1628-1639. doi: 10.1136/annrheumdis-2021-222006. Epub 2022 Feb 23.
8
Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.COVID-19 与风湿和肌肉骨骼疾病中的综合征与综合征发生：旧挑战，新时代。
Rheumatology (Oxford). 2021 May 14;60(5):2040-2045. doi: 10.1093/rheumatology/keaa840.
9
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.德国风湿病学会关于在SARS-CoV-2/COVID-19大流行背景下照顾炎性风湿性疾病患者的最新建议，包括COVID-19疫苗接种建议。
Z Rheumatol. 2021 Dec;80(Suppl 2):33-48. doi: 10.1007/s00393-021-01055-7. Epub 2021 Sep 7.
10
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.接种 SARS-CoV-2 疫苗在风湿免疫疾病患者中的安全性：来自 EULAR 冠状病毒疫苗（COVAX）医生报告登记处的结果。
Ann Rheum Dis. 2022 May;81(5):695-709. doi: 10.1136/annrheumdis-2021-221490. Epub 2021 Dec 31.

引用本文的文献

1
SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.风湿性疾病患者对 SARS-CoV-2 疫苗的接受度：一项横断面研究。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4048-4056. doi: 10.1080/21645515.2021.1958611. Epub 2021 Aug 6.